18 November 2017
News and Views
Links and Services
This month's issue of the Alimentary Pharmacology & Therapeutics investigates the duration of effect of infliximab maintenance treatment in pediatric Crohn’s disease.
Infliximab is effective for induction and maintenance of remission in children with moderately to
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors